By
 In News, WCCT News

Dr. Kenneth Kim Presentation at the CHEST 2012 Meeting in Atlanta, Georgia

Atlanta, GA: October 22, 2012

Dr. Kenneth Kim gave a presentation entitled “HPA Axis Effects of Mometasone Furoate/Formoterol (MF/F) Versus Fluticasone Propionate/Salmeterol (FP/S) Administered via Metered-Dose Inhaler (MDI)” at the CHEST 2012 Meeting in Atlanta, Georgia on October 22, 2012.  This study was conducted to compare effects of inhaled corticosteroids mometasone furoate (MF) and fluticasone propionate (FP) on the hypothalamic-pituitary-adrenal (HPA) axis when administered from combination MDI products in patients with asthma.

About ACCP:

The American College of Chest Physicians is a medical organization in the United States consisting of physicians and non-physician specialists in the field of chest medicine, which includes pulmonology, thoracic surgery, and critical care medicine.

About WCCT

WCCT is a privately owned early phase development contract research organization, conveniently located near 3 major airports in Southern California. WCCT was founded by Dr. Kenneth Kim who is board certified in Internal Medicine and Allergy and Immunology. Conducting trials since 1998, WCCT has been audited by the FDA and numerous pharmaceutical and biotechnology companies. WCCT’s location and access to an ethnically diverse population allows for a wide variety of study designs including ethnic bridging. With 150 beds in two locations and over 60,000 square feet, a well-trained and experienced staff, and advanced technological procedures, WCCT brings the highest quality to the pharmaceutical and biotechnology industries. (www.wcct.com)

To access the presentation: please email here.

Contact
WCCT Global
Business Development
mgr@wcct.com